Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $15.1 million.

  • Fortress Biotech's Cash from Financing Activities rose 45595.72% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.5 million, marking a year-over-year increase of 1027.44%. This contributed to the annual value of $70.6 million for FY2024, which is 11577.02% up from last year.
  • As of Q3 2025, Fortress Biotech's Cash from Financing Activities stood at $15.1 million, which was up 45595.72% from $4.5 million recorded in Q2 2025.
  • Fortress Biotech's Cash from Financing Activities' 5-year high stood at $78.7 million during Q1 2021, with a 5-year trough of -$30.4 million in Q2 2023.
  • For the 5-year period, Fortress Biotech's Cash from Financing Activities averaged around $21.0 million, with its median value being $18.6 million (2022).
  • Per our database at Business Quant, Fortress Biotech's Cash from Financing Activities tumbled by 111574.72% in 2023 and then skyrocketed by 45595.72% in 2025.
  • Over the past 5 years, Fortress Biotech's Cash from Financing Activities (Quarter) stood at $38.9 million in 2021, then plummeted by 52.19% to $18.6 million in 2022, then surged by 134.28% to $43.6 million in 2023, then tumbled by 40.84% to $25.8 million in 2024, then crashed by 41.59% to $15.1 million in 2025.
  • Its last three reported values are $15.1 million in Q3 2025, $4.5 million for Q2 2025, and $52.1 million during Q1 2025.